Derek Maetzold
Founder bij CASTLE BIOSCIENCES, INC.
Vermogen: 9 M $ op 31-03-2024
Profiel
Derek J.
Maetzold is the founder and currently holds the position of President, Chief Executive Officer & Director at Castle Biosciences, Inc., which was founded in 2007.
He is also currently a Director at AltheaDx, Inc. since 2021, Prelude Corp.
since 2022, Ocular Melanoma Foundation, and IMPACT Melanoma, Inc. In his former positions, Mr. Maetzold served as Director & Associate Director-Marketing at Amylin Pharmaceuticals, Inc. from 1996 to 1998, Senior Director-Business Development at Schering-Plough Corp.
from 1999 to 2003, Associate Director-Marketing at Sandoz Pharmaceuticals Corp.
from 1985 to 1996, Vice President-Sales & Marketing at Encysive Pharmaceuticals, Inc. from 2003 to 2008, and Account Supervisor at Integrated Communications Corp.
from 1998 to 1999.
Mr. Maetzold obtained his undergraduate degree from George Mason University and holds an MBA from the University of California, Riverside.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
1.51% | 12-04-2024 | 414 990 ( 1.51% ) | 9 M $ | 31-03-2024 |
Actieve functies van Derek Maetzold
| Bedrijven | Functie | Begin |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Founder | 01-09-2007 |
| ALTHEADX INC | Director/Board Member | 26-05-2021 |
| Ocular Melanoma Foundation | Director/Board Member | - |
Prelude Corp.
 Prelude Corp. BiotechnologyHealth Technology Prelude Corp. provides health related services. It offers new paradigm, predictive DCIS test, precision medicine, and clinical evidence services. The company was founded by Troy Bremer in 2009 and is headquartered in Laguna Hills, CA. | Director/Board Member | 02-02-2022 |
Eerdere bekende functies van Derek Maetzold
| Bedrijven | Functie | Einde |
|---|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Sales & Marketing | 01-05-2008 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 01-01-2003 |
Integrated Communications Corp.
 Integrated Communications Corp. Advertising/Marketing ServicesCommercial Services Integrated Communications Corp. creates advertisements for pharmaceutical companies. The company was founded on June 11, 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01-01-1999 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Director/Board Member | 01-01-1998 |
| Sandoz Pharmaceuticals Corp. | Sales & Marketing | 01-01-1996 |
Opleiding van Derek Maetzold
| George Mason University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
AltheaDx, Inc.
 AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA. | Health Technology |
Integrated Communications Corp.
Integrated Communications Corp. Advertising/Marketing ServicesCommercial Services Integrated Communications Corp. creates advertisements for pharmaceutical companies. The company was founded on June 11, 1985 and is headquartered in Parsippany, NJ. | Commercial Services |
| Sandoz Pharmaceuticals Corp. | |
Prelude Corp.
Prelude Corp. BiotechnologyHealth Technology Prelude Corp. provides health related services. It offers new paradigm, predictive DCIS test, precision medicine, and clinical evidence services. The company was founded by Troy Bremer in 2009 and is headquartered in Laguna Hills, CA. | Health Technology |
| Ocular Melanoma Foundation |
